US 10208059
Heterocyclic modulators of HIF activity for treatment of disease
granted A61KA61K31/4245A61K31/427
Quick answer
US patent 10208059 (Heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4245, A61K31/427, A61K31/437, A61K31/4439